Literature DB >> 32016528

Blood and fluid management during scoliosis surgery: a single-center retrospective analysis.

Eleni Koraki1, Chrysoula Stachtari2, Zoi Stergiouda1, Maria Stamatopoulou1, Anna Gkiouliava1, Freideriki Sifaki1, Stavros Chatzopoulos3, Anastasia Trikoupi1.   

Abstract

AIM: In the present retrospective study in scoliosis surgery, we hypothesized that application of a protocol for blood and fluid management, based on goal-directed fluid therapy, cell salvage and tranexamic acid, could lead to reduced allogeneic red blood cells transfusion. METHODS AND MATERIAL: Thirty-five patients, with American Society of Anesthesiologists physical status I/III, between 14 and 18 years scheduled for elective orthopedic surgery of scoliosis, with a planned intensive care unit admission, were enrolled in a retrospective observational study. Patients were divided in two groups. Patients in no-protocol group (Group noPro, n = 18) received a liberal intraoperative fluid therapy and patients in protocol group (Group Pro, n = 17) received fluid therapy managed according to a stroke volume variation-based protocol. The protocol included fluid therapy according to SVV monitor, permissive hypotension, tranexamic acid infusion, restrictive RBC trigger and use of perioperative cell savage. STATISTICAL ANALYSIS USED: Student's t test (2-tailed), Mann-Whitney test, Chi square test were used for statistical analysis of the data.
RESULTS: There were no significant differences between the two groups in demographic data and clinical characteristics. Infused crystalloids (p = .003) and transfused allogeneic red blood cells (p = .015) were lesser in Group Pro compared to Group noPro. On the other hand, diuresis (p < .001) and vasopressors administration (p = .042) were higher in Group Pro than in Group noPro.
CONCLUSION: The application of a protocol for blood and fluid management, based on goal-directed fluid therapy, cell salvage and tranexamic acid, was associated with less crystalloid fluid administration, less perioperative RBC transfusions and significantly better diuresis than patients in the no-protocol group in scoliosis surgery. REGISTRATION NUMBER: ClinicalTrials.gov Identifier: NCT03814239.

Entities:  

Keywords:  Cell saver; Goal-directed fluid therapy; Scoliosis; Stroke volume variation

Mesh:

Substances:

Year:  2020        PMID: 32016528     DOI: 10.1007/s00590-020-02637-y

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  4 in total

Review 1.  Intra-operative cell salvage: a fresh look at the indications and contraindications.

Authors:  Stephen A Esper; Jonathan H Waters
Journal:  Blood Transfus       Date:  2011-01-13       Impact factor: 3.443

2.  Esmolol versus dexmedetomidine in scoliosis surgery: study on intraoperative blood loss and hemodynamic changes.

Authors:  Osama A Ibraheim; Alsiddiky Abdulmonem; Jumana Baaj; Tariq Al Zahrani; Vincent Arlet
Journal:  Middle East J Anaesthesiol       Date:  2013-02

Review 3.  Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children.

Authors:  Ewan D McNicol; Aikaterini Tzortzopoulou; Roman Schumann; Daniel B Carr; Aman Kalra
Journal:  Cochrane Database Syst Rev       Date:  2016-09-19

4.  The role of peri-operative cell salvage in instrumented anterior correction of thoracolumbar scoliosis: a case-controlled study.

Authors:  Aun H Mirza; Ehab Aldlyami; Chandra Bhimarasetty; Alistair G Thompson; Jonathon Spilsbury; David S Marks
Journal:  Acta Orthop Belg       Date:  2009-02       Impact factor: 0.500

  4 in total
  2 in total

1.  Enhanced recovery after surgery (ERAS) protocol in spine surgery.

Authors:  Tungish Bansal; Alok D Sharan; Bhavuk Garg
Journal:  J Clin Orthop Trauma       Date:  2022-07-09

2.  First surgical experience treating scoliosis using HGT and ECMO: a case report.

Authors:  Oriol Pujol; Felipe Moreira; Joan Balcells; Rosario Nuño; Antonio Moreno; Ferran Pellise
Journal:  Spine Deform       Date:  2022-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.